As of 2026-09-17, the Relative Valuation of Madrigal Pharmaceuticals Inc (MDGL) is (327.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 523.26 USD, the upside of Madrigal Pharmaceuticals Inc based on Relative Valuation is -162.6%.
The range of the Relative Valuation is (289.00) - (382.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 27.1x | 23.2x |
| Forward P/E multiples | 18.6x - 27.6x | 23.3x |
| Fair Price | (289.00) - (382.05) | (327.77) |
| Upside | -155.2% - -173.0% | -162.6% |
| Date | P/E |
| 2026-09-16 | -37.42 |
| 2026-09-15 | -37.12 |
| 2026-09-14 | -38.31 |
| 2026-09-11 | -37.91 |
| 2026-09-10 | -37.82 |
| 2026-09-09 | -38.78 |
| 2026-09-08 | -37.89 |
| 2026-09-04 | -38.38 |
| 2026-09-03 | -38.49 |
| 2026-09-02 | -38.80 |
| 2026-09-01 | -38.21 |
| 2026-08-31 | -38.31 |
| 2026-08-28 | -37.86 |
| 2026-08-27 | -38.57 |
| 2026-08-26 | -38.22 |
| 2026-08-25 | -36.33 |
| 2026-08-24 | -36.32 |
| 2026-08-21 | -36.65 |
| 2026-08-20 | -36.82 |
| 2026-08-19 | -38.32 |
| 2026-08-18 | -37.20 |
| 2026-08-17 | -37.23 |
| 2026-08-14 | -36.00 |
| 2026-08-13 | -35.99 |
| 2026-08-12 | -38.03 |
| 2026-08-11 | -37.97 |
| 2026-08-10 | -36.55 |
| 2026-08-07 | -36.18 |
| 2026-08-06 | -36.20 |
| 2026-08-05 | -36.47 |
| 2026-08-04 | -36.00 |
| 2026-08-03 | -34.19 |
| 2026-07-31 | -33.15 |
| 2026-07-30 | -34.98 |
| 2026-07-29 | -38.79 |
| 2026-07-28 | -38.22 |
| 2026-07-27 | -39.10 |
| 2026-07-24 | -38.62 |
| 2026-07-23 | -38.54 |
| 2026-07-22 | -38.14 |
| 2026-07-21 | -38.79 |
| 2026-07-20 | -38.00 |
| 2026-07-17 | -39.26 |
| 2026-07-16 | -38.70 |
| 2026-07-15 | -39.03 |
| 2026-07-14 | -38.08 |
| 2026-07-13 | -37.67 |
| 2026-07-10 | -38.07 |
| 2026-07-09 | -39.72 |
| 2026-07-08 | -40.11 |